141 related articles for article (PubMed ID: 3264781)
41. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
42. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
43. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
Silverman ED; Laxer RM; Nelson DL; Rubin LA
J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
[TBL] [Abstract][Full Text] [Related]
44. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis.
van den Brink HR; van Wijk MJ; Geertzen RG; Bijlsma JW
J Rheumatol; 1994 Mar; 21(3):430-4. PubMed ID: 7911833
[TBL] [Abstract][Full Text] [Related]
45. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus.
Miyasaka N; Nakamura T; Russell IJ; Talal N
Clin Immunol Immunopathol; 1984 Apr; 31(1):109-17. PubMed ID: 6421522
[TBL] [Abstract][Full Text] [Related]
46. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
47. Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity.
Lauwerys BR; Van Snick J; Houssiau FA
Lupus; 2002; 11(6):384-7. PubMed ID: 12139377
[TBL] [Abstract][Full Text] [Related]
48. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
50. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
Lub-de Hooge MN; de Vries EG; de Jong S; Bijl M
Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
[TBL] [Abstract][Full Text] [Related]
51. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
52. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
[TBL] [Abstract][Full Text] [Related]
53. [The importance of determination of interleukin-10 in the blood of patients with systemic lupus erythematosus].
Scudla V; Horák P; Faltýnek L; Pospísil Z; Budíková M; Hermanová Z
Cas Lek Cesk; 1998 Jan; 137(2):44-7. PubMed ID: 9511265
[TBL] [Abstract][Full Text] [Related]
54. Binding capacity of sera from systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) to C3c. Evaluation by enzyme linked immunosorbent assay (ELISA).
Bringuier JP; Veysseyre CM; Martin C; Raffin T; Monier JC
Pathol Biol (Paris); 1984 Dec; 32(10):1029-32. PubMed ID: 6514386
[TBL] [Abstract][Full Text] [Related]
55. [The levels of circulating immune complexes and immunoglobulins in patients with systemic lupus erythematosus and rheumatoid arthritis].
Ternovoĭ KS; Gandzha IM; Babynina LIa; Volobueva ZV; Sukharenko NV; Dibrova TN; Selezneva TN; Ermekova VM
Vrach Delo; 1990 Apr; (4):48-50. PubMed ID: 2275166
[TBL] [Abstract][Full Text] [Related]
56. Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus.
al-Janadi M; al-Wabel A; Raziuddin S
Clin Immunol Immunopathol; 1994 Apr; 71(1):33-7. PubMed ID: 8137557
[TBL] [Abstract][Full Text] [Related]
57. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus.
Nockher WA; Wigand R; Schoeppe W; Scherberich JE
Clin Exp Immunol; 1994 Apr; 96(1):15-9. PubMed ID: 7512005
[TBL] [Abstract][Full Text] [Related]
58. Lactoferrin in rheumatoid arthritis and systemic lupus erythematous.
Tsai WJ; Liu HW; Yen JH; Chen JR; Lin SF; Chen TP
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Jan; 7(1):22-6. PubMed ID: 1990149
[TBL] [Abstract][Full Text] [Related]
59. Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?
Dantas AT; Marques CD; da Rocha Junior LF; Cavalcanti MB; Gonçalves SM; Cardoso PR; Mariz Hde A; Rego MJ; Duarte AL; Pitta Ida R; Pitta MG
Dis Markers; 2015; 2015():519638. PubMed ID: 26078482
[TBL] [Abstract][Full Text] [Related]
60. Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease.
Gonzalez-Alvaro I; Ortiz AM; Garcia-Vicuña R; Balsa A; Pascual-Salcedo D; Laffon A
Clin Exp Rheumatol; 2003; 21(5):639-42. PubMed ID: 14611115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
